CSL Plasma, a subsidiary of CSL Behring, is one of the world's largest collectors of human plasma. The company operates numerous plasma collection centers across the United States, with a growing presence in Europe (Germany, Hungary) and a center in China. Plasma collected by CSL Plasma is used by CSL Behring to produce life-saving therapies for patients with rare and serious diseases. Their mission focuses on a commitment to quality, safety, and the well-being of plasma donors and the patients who rely on their products.
Manages and supports the operations of CSL Plasma collection centers, including quality assurance, regulatory compliance, marketing, donor services, and administrative functions for its U.S. operations.
Located in a modern business park, the facility is designed to facilitate collaboration and operational excellence, featuring advanced IT infrastructure to manage a large network of collection centers.
A mission-driven environment centered around saving lives, with strong emphasis on safety, quality, and donor care. The culture likely supports a fast-paced setting focused on operational efficiency and continuous improvement.
Serves as the central hub for CSL Plasma's U.S. operations, crucial for ensuring a consistent supply of quality plasma for CSL Behring's life-saving therapies.
CSL Plasma directly operates an extensive network of over 300 plasma collection centers in the United States. It is also expanding its presence with centers in Europe (Germany and Hungary) and has a collection center in China (via a joint venture). The plasma collected is utilized by its parent company, CSL Behring, which has a global footprint for manufacturing and distributing life-saving therapies in more than 100 countries. CSL Behring's major manufacturing sites are located in the USA, Germany, Switzerland, and Australia (CSL Limited).
900 Broken Sound Parkway NW
Boca Raton
Florida
USA
Address: 1201 N. Kinzie Avenue, Bradley, IL 60915, USA
A key North American manufacturing hub for CSL Behring's immunoglobulin and specialty biotherapies, essential for processing plasma collected across the U.S. by CSL Plasma and other sources.
Address: Emil-von-Behring-Straße 76, 35041 Marburg, Germany
Central hub for CSL Behring's European R&D and manufacturing operations, contributing significantly to the development and production of innovative plasma-based treatments for global markets.
Address: Wankdorfstrasse 10, 3014 Bern, Switzerland
Important European manufacturing and R&D site for CSL Behring, specializing in plasma-derived therapies and contributing to CSL's innovation in biotechnology.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, CSL Plasma' leadership includes:
CSL Plasma has been backed by several prominent investors over the years, including:
CSL has experienced key leadership transitions over the past year, notably the appointment of a new General Manager for CSL Plasma and other strategic hires and retirements within the broader CSL organization to support its continued growth and strategic objectives.
Discover the tools CSL Plasma uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
CSL Plasma, as part of CSL Behring and the broader CSL Limited group, typically uses standardized corporate email formats. The most commonly observed format is combining the employee's first name and last name.
first.last@cslplasma.com
Format
jane.doe@cslplasma.com
Example
85%
Success rate
CSLPlasma.com • January 10, 2024
CSL Plasma announced the opening of a new plasma collection center in Hoffman Estates, Illinois. This expansion aims to increase plasma supply for life-saving therapies and provide local residents an opportunity to donate and be compensated for their time....more
CSL.com • February 13, 2024
CSL Limited announced robust financial results for the first half of fiscal year 2024, with reported revenue of $7.18 billion, up 11% at constant currency. The growth was driven by strong performance in CSL Behring, particularly immunoglobulins, and CSL Seqirus's differentiated product portfolio....more
CSL.com • November 1, 2023
CSL announced the appointment of Willy Pardiñas as the new Senior Vice President and General Manager of CSL Plasma, effective November 1, 2023. He succeeded Bill Campbell, who retired after a distinguished career with the company....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including CSL Plasma, are just a search away.